Posts

Showing posts with the label Biopsy Devices Market Share

Biopsy Devices Market Is Anticipated To Reach $2.33 Billion By 2020: Grand View Research, Inc.

Image
Global  biopsy devices market  is expected to reach USD 2.33 billion by 2020 and is expected to grow at a CAGR of 6.4%, according to a new report by Grand View Research. Growing prevalence of several forms of cancer and a considerable presence of unmet market demand for efficient and accurate cancer diagnostic procedures, especially in resource limited settings such as in emerging economies are expected to support future growth of the industry. According to international cancer agencies, by 2030 the number of cancer incidences is expected to reach over 23 million which is directly expected to affect the number of required biopsies. Furthermore, growth in the global geriatric population is also expected to contribute towards the growth for this market by triggering incidence rates of target ailments and disorders. U.S. biopsy devices market, by product, 2012 - 2020 (USD Million) Biopsy guidance systems were observed to account for the largest share of revenue...

Biopsy Devices Market Is Predicted To Grow Quickly Due To Growing Prevalence Of Several Forms Of Cancer Till 2020: Grand View Research, Inc.

Global  biopsy devices market  is expected to reach USD 2.33 billion by 2020 and is expected to grow at a CAGR of 6.4%, according to a new report by Grand View Research. Growing prevalence of several forms of cancer and a considerable presence of unmet market demand for efficient and accurate cancer diagnostic procedures, especially in resource limited settings such as in emerging economies are expected to support future growth of the industry. According to international cancer agencies, by 2030 the number of cancer incidences is expected to reach over 23 million which is directly expected to affect the number of required biopsies. Furthermore, growth in the global geriatric population is also expected to contribute towards the growth for this market by triggering incidence rates of target ailments and disorders. Biopsy guidance systems were observed to account for the largest share of revenue for 2013 owing to the technologically advanced and expensive nature of the...